Full Name
Dr David Marchant
Job Title
Associate Professor
University of Alberta
City (Work Address)
State/Province/County (Work Address)
Speaker Bio
I completed my Ph.D training in HIV at the Wohl Virion Centre, University College London, UK in 2006 and my PDF in cardio-pulmonary virology, St. Paul’s Hospital, UBC, Vancouver, Canada in 2012. I’m an Associate Professor and Tier II Canada Research Chair in Viral Pathogenesis in the Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology at the University of Alberta, Canada.

We are deciphering the receptors and host cell factors that mediate Respiratory Syncytial Virus (RSV) replication and the community transmission of RSV in Western Canada. I am the founder and CSO of Antibiddies Technologies Inc. that is a conduit through which we are commercializing RSV therapeutics technologies developed in the laboratory.

Our most recent discovery is the primary host cell entry receptor of RSV, IGF1R and how this regulates trafficking of the RSV coreceptor, NCL.
David Marchant